Last 12 months
Inside the activity.
0 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 9 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 10, 2025 Filed Jan 10, 2025 23:11 UTC |
PATTERSON LEONE DEVP, Chief Bus & Fin Officer
|
GrantRestricted Stock Unit · Derivative | 53,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-004358 · ownership.xml · derivative · entry 2 PATTERSON LEONE D · CIK 0001233539 · EVP, Chief Bus & Fin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,000 Underlying: Common Stock · 53,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of Issuer's common stock. F3 · derivative.exercise_date: RSUs vest in three equal annual installments beginning on first anniversary of grant date. F3 · derivative.expiration_date: RSUs vest in three equal annual installments beginning on first anniversary of grant date. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:11 UTC |
PATTERSON LEONE DEVP, Chief Bus & Fin Officer
|
GrantStock Option (Right to Buy) · Derivative | 79,000 | $0.00 Strike: $13.22 | $0.00 |
DisclosureSEC source: 0000950170-25-004358 · ownership.xml · derivative · entry 1 PATTERSON LEONE D · CIK 0001233539 · EVP, Chief Bus & Fin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,000 Underlying: Common Stock · 79,000 shares Expires 2035-01-09 F1 · derivative.exercise_date: Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 17:58 UTC |
Galbraith KennethDirector · Chair & CEO
|
GrantRestricted Stock Unit · Derivative | 192,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-004336 · ownership.xml · derivative · entry 2 Galbraith Kenneth · CIK 0001567045 · Director · Chair & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,000 Underlying: Common Stock · 192,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of Issuer's common stock. F3 · derivative.exercise_date: RSUs vest in three equal annual installments beginning on first anniversary of grant date. F3 · derivative.expiration_date: RSUs vest in three equal annual installments beginning on first anniversary of grant date. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 17:58 UTC |
Galbraith KennethDirector · Chair & CEO
|
GrantStock Option (Right to Buy) · Derivative | 288,000 | $0.00 Strike: $13.22 | $0.00 |
DisclosureSEC source: 0000950170-25-004336 · ownership.xml · derivative · entry 1 Galbraith Kenneth · CIK 0001567045 · Director · Chair & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,000 Underlying: Common Stock · 288,000 shares Expires 2035-01-09 F1 · derivative.exercise_date: Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:27 UTC |
EcoR1 Capital, LLCDirector · 10% owner
|
PurchaseCommon Stock | 204,098 | $13.13 | $2,678,990.35 |
DisclosureSEC source: 0000935836-25-000048 · ownership.xml · nonDerivative · entry 2 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Note Disclosed balance after: 15,411,078 F4 · shares: Qualified Fund purchased 191,791 of the shares purchased in this transaction. F5 · balance_after: After this transaction, Qualified Fund held 14,442,664 shares of the Issuer's Common Stock. F1 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 18:03 UTC |
Smith Jeffrey T LEVP & Chief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 53,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-004346 · ownership.xml · derivative · entry 2 Smith Jeffrey T L · CIK 0001604800 · EVP & Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,000 Underlying: Common Stock · 53,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of Issuer's common stock. F3 · derivative.exercise_date: RSUs vest in three equal annual installments beginning on first anniversary of grant date. F3 · derivative.expiration_date: RSUs vest in three equal annual installments beginning on first anniversary of grant date. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 18:03 UTC |
Smith Jeffrey T LEVP & Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 79,000 | $0.00 Strike: $13.22 | $0.00 |
DisclosureSEC source: 0000950170-25-004346 · ownership.xml · derivative · entry 1 Smith Jeffrey T L · CIK 0001604800 · EVP & Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,000 Underlying: Common Stock · 79,000 shares Expires 2035-01-09 F1 · derivative.exercise_date: Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:07 UTC |
Moore Paul AndrewChief Scientific Officer
|
GrantRestricted Stock Unit · Derivative | 53,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-004352 · ownership.xml · derivative · entry 2 Moore Paul Andrew · CIK 0001938192 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,000 Underlying: Common Stock · 53,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of Issuer's common stock. F3 · derivative.exercise_date: RSUs vest in three equal annual installments beginning on first anniversary of grant date. F3 · derivative.expiration_date: RSUs vest in three equal annual installments beginning on first anniversary of grant date. Read SEC document |
| January 10, 2025 Filed Jan 10, 2025 23:07 UTC |
Moore Paul AndrewChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 79,000 | $0.00 Strike: $13.22 | $0.00 |
DisclosureSEC source: 0000950170-25-004352 · ownership.xml · derivative · entry 1 Moore Paul Andrew · CIK 0001938192 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,000 Underlying: Common Stock · 79,000 shares Expires 2035-01-09 F1 · derivative.exercise_date: Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date. Read SEC document |
| January 08, 2025 Filed Jan 10, 2025 23:27 UTC |
EcoR1 Capital, LLCDirector · 10% owner
|
PurchaseCommon Stock | 21,021 | $14.07 | $295,828.53 |
DisclosureSEC source: 0000935836-25-000048 · ownership.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Note Disclosed balance after: 15,206,980 F2 · shares: Qualified Fund purchased 19,752 of the shares purchased in this transaction. F3 · balance_after: After this transaction, Qualified Fund held 14,250,873 shares of the Issuer's Common Stock. F1 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| January 06, 2025 Filed Jan 6, 2025 20:34 UTC |
Galbraith KennethDirector · Chair & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 66,666 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-002497 · ownership.xml · derivative · entry 6 Galbraith Kenneth · CIK 0001567045 · Director · Chair & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,334 Underlying: Common Stock · 66,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. F7 · derivative.exercise_date: The RSUS were granted on January 5, 2024 and vest in three equal annual installments beginning on the first anniversary of January 5, 2024. F7 · derivative.expiration_date: The RSUS were granted on January 5, 2024 and vest in three equal annual installments beginning on the first anniversary of January 5, 2024. Read SEC document |
| January 06, 2025 Filed Jan 6, 2025 20:34 UTC |
Galbraith KennethDirector · Chair & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 47,666 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-002497 · ownership.xml · derivative · entry 5 Galbraith Kenneth · CIK 0001567045 · Director · Chair & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,668 Underlying: Common Stock · 47,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. F6 · derivative.exercise_date: The RSUS were granted on January 5, 2023 and vest in three equal annual installments beginning on the first anniversary of January 5, 2023. F6 · derivative.expiration_date: The RSUS were granted on January 5, 2023 and vest in three equal annual installments beginning on the first anniversary of January 5, 2023. Read SEC document |
| January 06, 2025 Filed Jan 6, 2025 20:34 UTC |
Galbraith KennethDirector · Chair & CEO
|
SaleCommon Stock | 33,406 | $14.92 | $498,554.48 |
DisclosureSEC source: 0000950170-25-002497 · ownership.xml · nonDerivative · entry 4 Galbraith Kenneth · CIK 0001567045 · Director · Chair & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,803 F2 · kind: Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory "sell to cover" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.44 to $15.14, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 06, 2025 Filed Jan 6, 2025 20:34 UTC |
Galbraith KennethDirector · Chair & CEO
|
Exercise / conversionCommon Stock | 66,666 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-002497 · ownership.xml · nonDerivative · entry 3 Galbraith Kenneth · CIK 0001567045 · Director · Chair & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Represents shares of common stock issued upon vesting of one third of the RSUs granted on January 5, 2024. Read SEC document |
| January 06, 2025 Filed Jan 6, 2025 20:34 UTC |
Galbraith KennethDirector · Chair & CEO
|
SaleCommon Stock | 23,885 | $14.92 | $356,462.13 |
DisclosureSEC source: 0000950170-25-002497 · ownership.xml · nonDerivative · entry 2 Galbraith Kenneth · CIK 0001567045 · Director · Chair & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,543 F2 · kind: Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory "sell to cover" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.44 to $15.14, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 06, 2025 Filed Jan 6, 2025 20:34 UTC |
Galbraith KennethDirector · Chair & CEO
|
Exercise / conversionCommon Stock | 47,666 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-002497 · ownership.xml · nonDerivative · entry 1 Galbraith Kenneth · CIK 0001567045 · Director · Chair & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,428 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares of common stock issued upon vesting of one third of the restricted stock units ("RSUs") granted on January 5, 2023. Read SEC document |
| January 06, 2025 Filed Jan 6, 2025 20:19 UTC |
Smith Jeffrey T LEVP & Chief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-002490 · ownership.xml · derivative · entry 3 Smith Jeffrey T L · CIK 0001604800 · EVP & Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 20,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. F5 · derivative.exercise_date: The RSUS were granted on January 5, 2024 and vest in three equal annual installments beginning on the first anniversary of January 5, 2024. F5 · derivative.expiration_date: The RSUS were granted on January 5, 2024 and vest in three equal annual installments beginning on the first anniversary of January 5, 2024. Read SEC document |
| January 06, 2025 Filed Jan 6, 2025 20:19 UTC |
Smith Jeffrey T LEVP & Chief Medical Officer
|
SaleCommon Stock | 11,110 | $14.92 | $165,806.75 |
DisclosureSEC source: 0000950170-25-002490 · ownership.xml · nonDerivative · entry 2 Smith Jeffrey T L · CIK 0001604800 · EVP & Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,890 F2 · kind: Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory "sell to cover" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.44 to $15.14, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 06, 2025 Filed Jan 6, 2025 20:19 UTC |
Smith Jeffrey T LEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-002490 · ownership.xml · nonDerivative · entry 1 Smith Jeffrey T L · CIK 0001604800 · EVP & Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares of common stock issued upon vesting of one third of the restricted stock units ("RSUs") granted on January 5, 2024. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 01:35 UTC |
Moore Paul AndrewChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-002501 · ownership.xml · derivative · entry 6 Moore Paul Andrew · CIK 0001938192 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 20,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. F7 · derivative.exercise_date: The RSUS were granted on January 5, 2024 and vest in three equal annual installments beginning on the first anniversary of January 5, 2024. F7 · derivative.expiration_date: The RSUS were granted on January 5, 2024 and vest in three equal annual installments beginning on the first anniversary of January 5, 2024. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 01:35 UTC |
Moore Paul AndrewChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 17,166 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-002501 · ownership.xml · derivative · entry 5 Moore Paul Andrew · CIK 0001938192 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,168 Underlying: Common Stock · 17,166 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. F6 · derivative.exercise_date: The RSUS were granted on January 5, 2023 and vest in three equal annual installments beginning on the first anniversary of January 5, 2023. F6 · derivative.expiration_date: The RSUS were granted on January 5, 2023 and vest in three equal annual installments beginning on the first anniversary of January 5, 2023. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 01:35 UTC |
Moore Paul AndrewChief Scientific Officer
|
SaleCommon Stock | 11,408 | $14.92 | $170,254.13 |
DisclosureSEC source: 0000950170-25-002501 · ownership.xml · nonDerivative · entry 4 Moore Paul Andrew · CIK 0001938192 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,333 F2 · kind: Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory "sell to cover" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.44 to $15.14, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 01:35 UTC |
Moore Paul AndrewChief Scientific Officer
|
Exercise / conversionCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-002501 · ownership.xml · nonDerivative · entry 3 Moore Paul Andrew · CIK 0001938192 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Represents shares of common stock issued upon vesting of one third of the RSUs granted on January 5, 2024. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 01:35 UTC |
Moore Paul AndrewChief Scientific Officer
|
SaleCommon Stock | 9,792 | $14.92 | $146,136.79 |
DisclosureSEC source: 0000950170-25-002501 · ownership.xml · nonDerivative · entry 2 Moore Paul Andrew · CIK 0001938192 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,741 F2 · kind: Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory "sell to cover" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.44 to $15.14, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 06, 2025 Filed Jan 7, 2025 01:35 UTC |
Moore Paul AndrewChief Scientific Officer
|
Exercise / conversionCommon Stock | 17,166 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-002501 · ownership.xml · nonDerivative · entry 1 Moore Paul Andrew · CIK 0001938192 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents shares of common stock issued upon vesting of one third of the restricted stock units ("RSUs") granted on January 5, 2023. Read SEC document |
| January 02, 2025 Filed Jan 2, 2025 22:51 UTC |
EcoR1 Capital, LLCDirector · 10% owner
|
PurchaseCommon Stock | 157,880 | $14.78 | $2,333,403.25 |
DisclosureSEC source: 0000935836-25-000007 · ownership.xml · nonDerivative · entry 3 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Note Disclosed balance after: 15,185,959 F6 · shares: Qualified Fund purchased 152,346 of the shares purchased in this transaction. F7 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.7789 to $14.78, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote 7. F8 · balance_after: After this transaction, Qualified Fund held 14,231,121 shares of the Issuer's Common Stock F1 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 22:51 UTC |
EcoR1 Capital, LLCDirector · 10% owner
|
PurchaseCommon Stock | 146,501 | $14.57 | $2,134,446.32 |
DisclosureSEC source: 0000935836-25-000007 · ownership.xml · nonDerivative · entry 2 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Note Disclosed balance after: 15,028,079 F4 · shares: Qualified Fund purchased 61,501 of the shares purchased in this transaction. F5 · balance_after: After this transaction, Qualified Fund held 14,078,775 shares of the Issuer's Common Stock. F1 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 22:51 UTC |
EcoR1 Capital, LLCDirector · 10% owner
|
PurchaseCommon Stock | 58,988 | $14.47 | $853,326.31 |
DisclosureSEC source: 0000935836-25-000007 · ownership.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Note Disclosed balance after: 14,881,578 F2 · shares: Qualified Fund purchased 55,513 of the shares purchased in this transaction. F3 · balance_after: After this transaction, Qualified Fund held 14,017,274 shares of the Issuer's Common Stock. F1 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 27, 2024 Filed Dec 27, 2024 23:41 UTC |
EcoR1 Capital, LLCDirector · 10% owner
|
PurchaseCommon Stock | 101,659 | $14.49 | $1,473,181.23 |
DisclosureSEC source: 0000935836-24-000785 · ownership.xml · nonDerivative · entry 3 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Note Disclosed balance after: 14,822,590 F7 · shares: Qualified Fund purchased 95,672 of the shares purchased in this transaction. F8 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.2405 to $14.50, inclusive. F9 · balance_after: After this transaction, Qualified Fund held 13,961,761 shares of the Issuer's Common Stock. F1 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 26, 2024 Filed Dec 27, 2024 23:41 UTC |
EcoR1 Capital, LLCDirector · 10% owner
|
PurchaseCommon Stock | 16,692 | $14.38 | $240,037.64 |
DisclosureSEC source: 0000935836-24-000785 · ownership.xml · nonDerivative · entry 2 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Note Disclosed balance after: 14,720,931 F5 · shares: Qualified Fund purchased 15,707 of the shares purchased in this transaction. F6 · balance_after: After this transaction, Qualified Fund held 13,866,089 shares of the Issuer's Common Stock. F1 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 24, 2024 Filed Dec 27, 2024 23:41 UTC |
EcoR1 Capital, LLCDirector · 10% owner
|
PurchaseCommon Stock | 11,958 | $14.12 | $168,895.99 |
DisclosureSEC source: 0000935836-24-000785 · ownership.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Note Disclosed balance after: 14,704,239 F2 · shares: Qualified Fund purchased 11,254 of the shares purchased in this transaction. F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.9473 and $14.14 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes 3 and 8. F4 · balance_after: After this transaction, Qualified Fund held 13,850,382 shares of the Issuer's Common Stock. F1 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 23, 2024 Filed Dec 26, 2024 17:46 UTC Amendment |
EcoR1 Capital, LLCDirector · 10% owner
|
PurchaseCommon Stock | 251,502 | $14.25 | $3,584,104.70 |
DisclosureSEC source: 0000935836-24-000780 · ownership.xml · nonDerivative · entry 3 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Note Disclosed balance after: 14,692,281 F1 · security: This transaction was inadvertently omitted from the Form 4 filed on 12/23/2024. F9 · shares: Qualified Fund purchased 236,691 of the shares purchased in this transaction. F10 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.1957 to $14.2713, inclusive. F11 · balance_after: After this transaction, Qualified Fund held 13,839,128 shares of the Issuer's Common Stock. F2 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 20, 2024 Filed Dec 26, 2024 17:46 UTC Amendment |
EcoR1 Capital, LLCDirector · 10% owner
|
PurchaseCommon Stock | 704,488 | $14.08 | $9,917,500.27 |
DisclosureSEC source: 0000935836-24-000780 · ownership.xml · nonDerivative · entry 2 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Note Disclosed balance after: 14,440,779 F1 · security: This transaction was inadvertently omitted from the Form 4 filed on 12/23/2024. F6 · shares: Qualified Fund purchased 662,995 of the shares purchased in this transaction. F7 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.6517 to $14.1388, inclusive. F8 · balance_after: After this transaction, Qualified Fund held 13,602,437 shares of the Issuer's Common Stock. F2 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 19, 2024 Filed Dec 26, 2024 17:46 UTC Amendment |
EcoR1 Capital, LLCDirector · 10% owner
|
PurchaseCommon Stock | 298,818 | $13.53 | $4,042,678.84 |
DisclosureSEC source: 0000935836-24-000780 · ownership.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Note Disclosed balance after: 13,736,291 F1 · security: This transaction was inadvertently omitted from the Form 4 filed on 12/23/2024. F3 · shares: Qualified Fund purchased 281,218 of the shares purchased in this transaction. F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.3758 to $13.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes 4, 7 and 10. F5 · balance_after: After this transaction, Qualified Fund held 12,939,442 shares of the Issuer's Common Stock. F2 · ownership.nature: The reporting persons are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The filers disclaim beneficial ownership of the securities except to the extent of their respective pecuniary interests therein. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 17:52 UTC |
Davidson NancyDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $13.06 | $0.00 |
DisclosureSEC source: 0000950170-24-135923 · ownership.xml · derivative · entry 1 Davidson Nancy · CIK 0002002946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2034-12-09 F1 · derivative.exercise_date: Stock options vest on date of next annual general meeting following grant date of December 10, 2024. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 22:49 UTC |
Gallagher NeilDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $13.06 | $0.00 |
DisclosureSEC source: 0000950170-24-135919 · ownership.xml · derivative · entry 1 Gallagher Neil · CIK 0001972849 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2034-12-09 F1 · derivative.exercise_date: Stock options vest on date of next annual general meeting following grant date of December 10, 2024. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 22:51 UTC |
Mahony SusanDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $13.06 | $0.00 |
DisclosureSEC source: 0000950170-24-135921 · ownership.xml · derivative · entry 1 Mahony Susan · CIK 0001463321 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2034-12-09 F1 · derivative.exercise_date: Stock options vest on date of next annual general meeting following grant date of December 10, 2024. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 17:56 UTC |
Neu KelvinDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $13.06 | $0.00 |
DisclosureSEC source: 0000950170-24-135928 · ownership.xml · derivative · entry 1 Neu Kelvin · CIK 0001554699 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2034-12-09 F1 · derivative.exercise_date: Stock options vest on date of next annual general meeting following grant date of December 10, 2024. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 22:52 UTC |
Cox TroyDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $13.06 | $0.00 |
DisclosureSEC source: 0000950170-24-135922 · ownership.xml · derivative · entry 1 Cox Troy · CIK 0001696923 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2034-12-09 F1 · derivative.exercise_date: Stock options vest on date of next annual general meeting following grant date of December 10, 2024. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 18:15 UTC |
Campoy CarlosDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $13.06 | $0.00 |
DisclosureSEC source: 0000950170-24-135948 · ownership.xml · derivative · entry 1 Campoy Carlos · CIK 0001761518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2034-12-09 F1 · derivative.exercise_date: Stock options vest on date of next annual general meeting following grant date of December 10, 2024. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 23:01 UTC |
Cesano AlessandraDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $13.06 | $0.00 |
DisclosureSEC source: 0000950170-24-135932 · ownership.xml · derivative · entry 1 Cesano Alessandra · CIK 0001827015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2034-12-09 F1 · derivative.exercise_date: Stock options vest on date of next annual general meeting following grant date of December 10, 2024. Read SEC document |
| December 10, 2024 Filed Dec 12, 2024 23:20 UTC |
Miller Derek John MichaelDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $13.06 | $0.00 |
DisclosureSEC source: 0000950170-24-135950 · ownership.xml · derivative · entry 1 Miller Derek John Michael · CIK 0001971973 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2034-12-09 F1 · derivative.exercise_date: Stock options vest on date of next annual general meeting following grant date of December 10, 2024. Read SEC document |
| September 01, 2024 Filed Sep 3, 2024 21:50 UTC |
PATTERSON LEONE DEVP, Chief Bus & Fin Officer
|
GrantStock Option (Right to Buy) · Derivative | 360,000 | $0.00 Strike: $11.73 | $0.00 |
DisclosureSEC source: 0000950170-24-102982 · ownership.xml · derivative · entry 1 PATTERSON LEONE D · CIK 0001233539 · EVP, Chief Bus & Fin Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 360,000 Underlying: Common Stock · 360,000 shares Expires 2034-08-31 F1 · derivative.exercise_date: Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date. Read SEC document |
| April 02, 2024 Filed Apr 3, 2024 01:54 UTC |
Gallagher NeilDirector
|
GrantStock Option (Right to Buy) · Derivative | 74,000 | $0.00 Strike: $9.23 | $0.00 |
DisclosureSEC source: 0000950170-24-040632 · ownership.xml · derivative · entry 1 Gallagher Neil · CIK 0001972849 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,000 Underlying: Common Stock · 74,000 shares Expires 2034-04-01 F1 · derivative.exercise_date: Stock options vest in 36 equal monthly installments starting one month after grant date of April 2, 2024. Read SEC document |
| February 08, 2024 Filed Feb 9, 2024 23:15 UTC |
Cesano AlessandraDirector
|
GrantStock Option (Right to Buy) · Derivative | 74,000 | $0.00 Strike: $11.47 | $0.00 |
DisclosureSEC source: 0000950170-24-013427 · ownership.xml · derivative · entry 1 Cesano Alessandra · CIK 0001827015 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,000 Underlying: Common Stock · 74,000 shares Expires 2034-02-07 F1 · derivative.exercise_date: Stock options vest in 36 equal monthly installments starting one month after grant date of February 8, 2024. Read SEC document |
| January 08, 2024 Filed Jan 8, 2024 18:23 UTC |
Galbraith KennethDirector · Chair & CEO
|
SaleCommon Stock | 5,706 | $11.22 | $63,996.21 |
DisclosureSEC source: 0000950170-24-003099 · ownership.xml · nonDerivative · entry 3 Galbraith Kenneth · CIK 0001567045 · Director · Chair & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,762 F2 · kind: Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory "sell to cover" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.49 to $11.58, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 08, 2024 Filed Jan 8, 2024 18:14 UTC |
Astle ChristopherSVP & Chief Financial Officer
|
SaleCommon Stock | 1,431 | $11.22 | $16,049.52 |
DisclosureSEC source: 0000950170-24-003087 · ownership.xml · nonDerivative · entry 3 Astle Christopher · CIK 0001915257 · SVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,503 F2 · kind: Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory "sell to cover" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.49 to $11.58, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 08, 2024 Filed Jan 8, 2024 23:01 UTC |
Moore Paul AndrewChief Scientific Officer
|
SaleCommon Stock | 2,339 | $11.22 | $26,233.29 |
DisclosureSEC source: 0000950170-24-003076 · ownership.xml · nonDerivative · entry 3 Moore Paul Andrew · CIK 0001938192 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,367 F2 · kind: Represents shares of common stock sold to cover tax withholding obligations and other applicable fees in connection with the vesting of RSUs pursuant to mandatory "sell to cover" provisions contained in the Reporting Person's applicable RSU grant agreement, and does not represent a discretionary sale by the Reporting Person. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.49 to $11.58, inclusive. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 18:23 UTC |
Galbraith KennethDirector · Chair & CEO
|
GrantRestricted Stock Unit · Derivative | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-003099 · ownership.xml · derivative · entry 6 Galbraith Kenneth · CIK 0001567045 · Director · Chair & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires not disclosed F5 · derivative.exercise_price: Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock. F8 · derivative.exercise_date: The RSUs vest in three equal annual installments beginning on January 5, 2025. F8 · derivative.expiration_date: The RSUs vest in three equal annual installments beginning on January 5, 2025. Read SEC document |
| January 05, 2024 Filed Jan 8, 2024 18:23 UTC |
Galbraith KennethDirector · Chair & CEO
|
GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $10.56 | $0.00 |
DisclosureSEC source: 0000950170-24-003099 · ownership.xml · derivative · entry 5 Galbraith Kenneth · CIK 0001567045 · Director · Chair & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2034-01-04 F7 · derivative.exercise_date: Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.